Prucalopride

Chemical formula: C₁₈H₂₆ClN₃O₃  Molecular mass: 367.87 g/mol  PubChem compound: 3052762

Therapeutic indications

Prucalopride is indicated for:

Chronic constipation

Population group: women, only elderly (65 years old or older)

Prucalopride is indicated for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Chronic constipation

Population group: women, only adults (18 - 65 years old)

Prucalopride is indicated for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Prucalopride is contraindicated in the following cases:

Intestinal perforation, intestinal obstruction, inflammatory conditions of the intestinal tract

at least one of
Perforation of intestine
Intestinal obstruction
Enteritis, inflammatory disorder of small intestine
Inflammation of large intestine

Dialysis

Renal dialysis

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: RESOLOR Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈